Fabio Zuccotto

University of Dundee

United Kingdom

Research Interests

Explore related searches

Professors in United Kingdom

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (11)

Year:

2024

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Collaborators (8)

Nicola Baker

University of York

UNITED KINGDOM

View details

Richard J. Wall

Assistant Professor

London School of Hygiene & Tropical Medicine

UNITED KINGDOM

View details

Luciana Paradela

University of Dundee

UNITED KINGDOM

View details

David Gray

Head of Biology

University of Dundee

UNITED KINGDOM

View details

Alan Fairlamb

Emeritus Professor and Associate

University of Dundee

UNITED KINGDOM

View details

Ian Gilbert

University of Dundee

UNITED KINGDOM

View details

Beatriz Baragaña

Academic, Principal Investigator/Senior Lecturer (Teaching and Research)

University of Dundee

UNITED KINGDOM

View details

Manu De Rycker

Academic, Principal Investigator/Senior Lecturer (Teaching and Research)

University of Dundee

UNITED KINGDOM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Fabio Zuccotto

Research Interests

Explore related searches

Contact this professor

Articles (11)

Application of an NMR/Crystallography Fragment Screening Platform for the Assessment and Rapid Discovery of New HIV‐CA Binding Fragments

SophosQM: Accurate Binding Affinity Prediction in Compound Optimization

Lysyl-tRNA synthetase, a target for urgently needed M. tuberculosis drugs

Repositioning of a diaminothiazole series confirmed to target the cyclin-dependent kinase CRK12 for use in the treatment of African animal trypanosomiasis

Identification of a proteasome-targeting arylsulfonamide with potential for the treatment of Chagas' disease

Optimization of TAM16, a Benzofuran That Inhibits the Thioesterase Activity of Pks13; Evaluation toward a Preclinical Candidate for a Novel Antituberculosis Clinical Target

Scaffold-Hopping Strategy on a Series of Proteasome Inhibitors Led to a Preclinical Candidate for the Treatment of Visceral Leishmaniasis

DNDI-6148

Ligand binding

Multiple unbiased approaches identify oxidosqualene cyclase as the molecular target of a promising anti-leishmanial

Spirocycle MmpL3 Inhibitors with Improved hERG and Cytotoxicity Profiles as Inhibitors of Mycobacterium tuberculosis Growth

Collaborators (8)

Nicola Baker

Richard J. Wall

Luciana Paradela

David Gray

Alan Fairlamb

Ian Gilbert

Beatriz Baragaña

Manu De Rycker

Make your next move.